carbostyril has been researched along with Cardiovascular Stroke in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Desai, T; Edhi, AI; Hakim, S | 1 |
| Butler, AM; O'Halloran, JA; Olsen, MA; Powderly, WG; Sahrmann, J | 1 |
| Gluud, C; Hróbjartsson, A; Jakobsen, JC; Korang, SK; Safi, S; Sethi, NJ; Skoog, M | 1 |
| Calzetta, L; Capuano, A; Donniacuo, M; Gritti, G; Martuscelli, E; Matera, MG; Orlandi, A; Rafaniello, C; Rinaldi, B; Rossi, F; Sodano, L | 1 |
| Ahmad, F; Backx, PH; Bae, DH; Brantner, CA; Chen, Y; Chung, YW; Daniels, MP; Esfahani, SG; Gucek, M; Hockman, SC; Lagranha, C; Lee, BS; Manganiello, VC; Murphy, E; Polidovitch, N; Rhee, DK; Sun, J; Tong, G; Wu, J | 1 |
| Boer, R; Bürkle, A; Eltze, T; Klein, T; McDonald, MC; Thiemermann, C; Wagner, T; Weinbrenner, S | 1 |
| Hauser, D; Ladds, B; Mejia, C; Thomas, P | 1 |
| Ariazi, JL; Bao, W; Behm, DJ; Duffy, KJ; Erickson-Miller, CL; Hu, E; Jucker, BM; Lepore, JJ; Needle, S; Olzinski, AR; Pipes, GC; Qin, P; Willette, RN; Zhao, S | 1 |
| Afzal, F; Aronsen, JM; Hussain, RI; Krobert, KA; Levy, FO; Osnes, JB; Sjaastad, I; Skomedal, T | 1 |
| Bourke, BN; Dione, DP; Edwards, DS; Giordano, FJ; Harris, TD; Krassilnikova, S; Liu, S; Madri, JA; Meoli, DF; Sadeghi, MM; Sinusas, AJ; Su, H; Zaret, BL | 1 |
| Charles, CJ; Donald, RA; Ikram, H; Prickett, T; Richards, AM | 1 |
| Fujita, H; Iwao, H; Miura, K; Omura, T; Takeuchi, K; Yamagishi, H; Yoshikawa, J; Yoshiyama, M | 1 |
| Knirsch, C; Luchsinger, JA; Pablos-Méndez, A; Rabinowitz, D; Shea, S | 1 |
| Asanoi, H; Fujita, M; Ishizaka, S; Kameyama, T; Nozawa, T; Sasayama, S | 1 |
1 review(s) available for carbostyril and Cardiovascular Stroke
| Article | Year |
|---|---|
Antibiotics for secondary prevention of coronary heart disease.
Topics: Anti-Bacterial Agents; Cardiovascular Diseases; Cause of Death; Coronary Disease; Death, Sudden, Cardiac; Humans; Macrolides; Middle Aged; Myocardial Infarction; Quinolones; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2021 |
13 other study(ies) available for carbostyril and Cardiovascular Stroke
| Article | Year |
|---|---|
Eradicating H. pylori.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Drug Therapy, Combination; Esophageal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Mortality; Myocardial Infarction; Patient Selection; Practice Guidelines as Topic; Quinolones; Risk; Risk Assessment; Stomach Neoplasms; United States | 2019 |
Brief Report: Integrase Strand Transfer Inhibitors Are Associated With Lower Risk of Incident Cardiovascular Disease in People Living With HIV.
Topics: Adult; Anti-Retroviral Agents; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Ischemic Stroke; Male; Middle Aged; Myocardial Infarction; Oxazines; Piperazines; Pyridones; Quinolones; Raltegravir Potassium; Retrospective Studies | 2020 |
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Heart Rate; Indans; Male; Metoprolol; Myocardial Infarction; Quinolones; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Ventricular Remodeling | 2015 |
Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.
Topics: Animals; Caveolin 3; Connexin 43; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Mice; Mice, Knockout; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phosphodiesterase Inhibitors; Quinolones | 2015 |
Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
Topics: Animals; Cell Line; Cell Line, Tumor; Fibroblasts; Humans; Imidazoles; Isoquinolines; Kinetics; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Pyridines; Quinolones; Rats; Rats, Wistar; Recombinant Proteins; Solubility; Structure-Activity Relationship | 2008 |
Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Creatine Kinase; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Myocardial Infarction; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; Risperidone; Schizophrenia; Valproic Acid | 2009 |
Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat.
Topics: Animals; Cell Line; Coronary Vessels; Glycine; Hemodynamics; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocardial Infarction; Procollagen-Proline Dioxygenase; Quinolones; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Ventricular Remodeling | 2010 |
The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Carbachol; Cardiotonic Agents; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Failure; Heart Ventricles; In Vitro Techniques; Isoproterenol; Male; Muscarinic Agonists; Myocardial Contraction; Myocardial Infarction; Pertussis Toxin; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Quinolones; Rats; Rats, Wistar; Rolipram; Ventricular Pressure | 2013 |
Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.
Topics: Animals; Cells, Cultured; Coronary Vessels; Diagnostic Imaging; Dogs; Endothelial Cells; Endothelium, Vascular; Hemodynamics; Indium Radioisotopes; Integrin alphaVbeta3; Male; Molecular Structure; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Quinolones; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2004 |
Arginine vasopressin V1-receptor antagonism in an ovine model of acute myocardial infarction.
Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Halothane; Hemodynamics; Myocardial Infarction; Piperidines; Quinolones; Renin; Sheep | 1998 |
The effect of vasopressin V1- and V2-receptor antagonists on hemodynamics in early and late phase after myocardial infarction in rats.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Ventricles; Hemodynamics; Male; Myocardial Infarction; Organ Size; Piperidines; Quinolones; Rats; Rats, Wistar; Time Factors; Vasopressins; Ventricular Function, Left | 1998 |
Relation of antibiotic use to risk of myocardial infarction in the general population.
Topics: Anti-Bacterial Agents; Cephalosporins; Chlamydophila Infections; Chlamydophila pneumoniae; Databases, Factual; Female; Humans; Insurance; Macrolides; Male; Medical Records; Middle Aged; Myocardial Infarction; Penicillins; Pneumonia, Bacterial; Proportional Hazards Models; Quinolones; Retrospective Studies; Risk Factors; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2002 |
[End-systolic pressure-volume relationships obtained by conductance catheter and transient inferior vena caval occlusion: their clinical usefulness].
Topics: Adult; Aged; Cardiac Catheterization; Cardiotonic Agents; Dobutamine; Drug Evaluation; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Quinolones; Systole; Vena Cava, Inferior; Ventricular Function, Left | 1991 |